Results 141 to 150 of about 12,460 (212)

Surveillance for invasive candidiasis in China (CHIF-NET 2018-2021): rising antifungal resistance observed in a nationwide longitudinal study. [PDF]

Antimicrob Agents Chemother
Yi Q-L, Xu K-W, Guo P-H, Li L, Ma L, Liu Y, Li N, Huang X-C, He H, Xia W-Y, Guan J, Li J, Zhang G, Kang W, Zhang J-J, Wang T, Gao H-T, Guo D, Xu Y-C, Xiao M, China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study Group.   +20 more
europepmc   +1 more source

An introduction to the future of echinocandin therapy [PDF]

Journal of Antimicrobial Chemotherapy, 2018
openaire   +3 more sources

SCY-247, a novel second-generation triterpenoid antifungal, demonstrates high in vitro activity against genetically diverse Candida auris isolates, including FKS1 mutants. [PDF]

J Antimicrob Chemother
Spruijtenburg B, de Groot T, Meijer EFJ.
europepmc   +1 more source

Diagnosis and management of invasive candidiasis in critically ill patients: SIAARTI multidisciplinary statement. [PDF]

J Anesth Analg Crit Care
Cortegiani A, De Pascale G, De Angelis G, Falcone M, Ferrini A, Forniti A, Gatti M, Girardis M, Grasselli G, Pea F, Rinaldi M, Sanguinetti M, Viale P, Giarratano A.   +13 more
europepmc   +1 more source

Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice. [PDF]

Mycoses
Boán J, Aparicio-Minguijón E, Fernández-Ruiz M, Pérez-Jacoiste Asín MA, Rodríguez-Goncer I, López-Medrano F, San-Juan R, Silva JT, Pérez-Ayala A, Caro-Teller JM, Aguado JM.   +10 more
europepmc   +1 more source

Rezafungin in fluconazole-resistant and refractory candidiasis: the first Brazilian experience. [PDF]

Rev Inst Med Trop Sao Paulo
Kruschewsky WLL, Nakagawa JAS, Siqueira LPM, Taborda M, de Oliveira VF, Abdala E, Magri ASGK, Magri MMC.   +7 more
europepmc   +1 more source

Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in <i>Candida auris</i> (<i>Candidozyma auris</i>) Isolates. [PDF]

Infect Drug Resist
Turan D, Sarmis A, Adaleti R, Aksaray S.
europepmc   +1 more source

Efficacy and safety of echinocandins combined with Trimethoprim-Sulfamethoxazole as first-line treatment for Pneumocystis pneumonia in HIV-infected and non-HIV-infected patients. [PDF]

BMC Infect Dis
Xie J, Gao A, Zhang W, Zhao D, Liu W.
europepmc   +1 more source

Test Performance and Clinical Utility of the Cobas Eplex Blood Culture Identification Fungal Pathogen Panel. [PDF]

Open Forum Infect Dis
Riegler AN, Carmona S, Meeder J, Moates D, Lee RA, McCarty TP, Leal SM.   +6 more
europepmc   +1 more source

Treatment Options and Antifungal Resistance in Pediatric Candidozyma auris (Previously Candida auris) Infections: A Systematic Review of Clinical Outcomes. [PDF]

Microorganisms
Stergiou K, Skourtsidis K, Kiosis G, Ioannou D, Tseriotis VS, Fouskas V, Karachrysafi S, Iosifidis E, Roilides E, Papamitsou T, Kourti M.   +10 more
europepmc   +1 more source